Kazutoshi Murakami

2.2k total citations
73 papers, 1.7k citations indexed

About

Kazutoshi Murakami is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Behavioral Neuroscience. According to data from OpenAlex, Kazutoshi Murakami has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Behavioral Neuroscience. Recurrent topics in Kazutoshi Murakami's work include Stress Responses and Cortisol (14 papers), Neuroendocrine regulation and behavior (8 papers) and Hormonal Regulation and Hypertension (6 papers). Kazutoshi Murakami is often cited by papers focused on Stress Responses and Cortisol (14 papers), Neuroendocrine regulation and behavior (8 papers) and Hormonal Regulation and Hypertension (6 papers). Kazutoshi Murakami collaborates with scholars based in Japan, United States and China. Kazutoshi Murakami's co-authors include Kozo Hashimoto, Jun Wada, Atsuko Nakatsuka, Zensuke Ota, Jun Eguchi, Hirofumi Makino, William F. Ganong, Sanae Teshigawara, Akihiro Katayama and Motoko Kanzaki and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Kazutoshi Murakami

70 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazutoshi Murakami Japan 23 506 328 316 309 282 73 1.7k
N Surico Italy 25 552 1.1× 420 1.3× 259 0.8× 81 0.3× 675 2.4× 100 2.6k
Masuo Akahane Japan 19 412 0.8× 297 0.9× 150 0.5× 37 0.1× 309 1.1× 60 1.5k
A. Mancini Italy 25 407 0.8× 106 0.3× 384 1.2× 93 0.3× 165 0.6× 73 1.5k
Hiroshi Eguchi Japan 27 563 1.1× 553 1.7× 144 0.5× 42 0.1× 622 2.2× 96 2.9k
Robert Gyurko United States 25 848 1.7× 211 0.6× 313 1.0× 30 0.1× 669 2.4× 42 2.8k
Jean‐Marie Villette France 20 441 0.9× 93 0.3× 523 1.7× 137 0.4× 314 1.1× 38 1.4k
Hyun Ah Kim South Korea 30 866 1.7× 300 0.9× 140 0.4× 58 0.2× 217 0.8× 82 2.5k
Fabio Benigni Italy 25 610 1.2× 176 0.5× 114 0.4× 75 0.2× 150 0.5× 73 2.0k
Margaret Bresnahan United States 20 530 1.0× 114 0.3× 161 0.5× 53 0.2× 174 0.6× 36 2.1k
Ana C. Liberman Argentina 18 424 0.8× 59 0.2× 364 1.2× 150 0.5× 141 0.5× 38 1.4k

Countries citing papers authored by Kazutoshi Murakami

Since Specialization
Citations

This map shows the geographic impact of Kazutoshi Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazutoshi Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazutoshi Murakami more than expected).

Fields of papers citing papers by Kazutoshi Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazutoshi Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazutoshi Murakami. The network helps show where Kazutoshi Murakami may publish in the future.

Co-authorship network of co-authors of Kazutoshi Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Kazutoshi Murakami. A scholar is included among the top collaborators of Kazutoshi Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazutoshi Murakami. Kazutoshi Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yorifuji, Takashi, et al.. (2023). Disease and Injury Trends following Heavy Rains in Western Japan in 2018. JMA Journal. 6(2). 129–137. 1 indexed citations
2.
Eguchi, Jun, Kazutoshi Murakami, Shinji Kamei, et al.. (2022). Circulating GPIHBP1 levels and microvascular complications in patients with type 2 diabetes: A cross-sectional study. Journal of clinical lipidology. 16(2). 237–245. 3 indexed citations
3.
Murakami, Kazutoshi, et al.. (2018). Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method. Journal of Visualized Experiments. 12 indexed citations
4.
Watanabe, Mayu, Atsuko Nakatsuka, Kazutoshi Murakami, et al.. (2014). Pemt Deficiency Ameliorates Endoplasmic Reticulum Stress in Diabetic Nephropathy. PLoS ONE. 9(3). e92647–e92647. 20 indexed citations
5.
Wada, Jun, Motoko Kanzaki, Sanae Teshigawara, et al.. (2013). Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease. BMC Nephrology. 14(1). 23–23. 52 indexed citations
6.
Inoue, Kentaro, Jun Wada, Jun Eguchi, et al.. (2013). Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray. PLoS ONE. 8(10). e77118–e77118. 49 indexed citations
7.
Kanzaki, Motoko, Jun Wada, Atsuko Nakatsuka, et al.. (2012). A Case of Type 2 Diabetes and Metastatic Liver Cancer Exhibiting Hypercholesterolemia with Abnormal Lipoproteins. Internal Medicine. 51(6). 619–623. 1 indexed citations
8.
Hirasaki, Shoji, et al.. (2012). Long-term Taenia saginata Infection Successfully Treated with Meglumine/Diatrizoate Sodium. Internal Medicine. 51(2). 177–179. 6 indexed citations
9.
Mutoh, Nobuyoshi, et al.. (2011). FRONT-AND-REAR-WHEEL-INDEPENDENT-DRIVE-TYPE ELECTRIC VEHICLE (FRID EV) TAKING THE LEAD FOR NEXT GENERATION ECO-VEHICLES. SAE technical papers on CD-ROM/SAE technical paper series. 1. 15 indexed citations
10.
Kanzaki, Motoko, Jun Wada, Koichi Sugiyama, et al.. (2011). Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes. Endocrinology. 153(2). 612–620. 73 indexed citations
11.
Nakatsuka, Atsuko, Jun Wada, Kazuyuki Hida, et al.. (2011). RXR antagonism induces G0/G1 cell cycle arrest and ameliorates obesity by up‐regulating the p53–p21$^{\rm{Cip1}}$ pathway in adipocytes. The Journal of Pathology. 226(5). 784–795. 21 indexed citations
13.
Hiramatsu, Yuji, Hisashi Masuyama, Makoto Ishida, Kazutoshi Murakami, & Masaru Sakurai. (2005). Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.. PubMed. 59(5). 235–8. 10 indexed citations
14.
Watanabe, Naomi, et al.. (2002). [A case of eosinophilic gastroenteritis caused by brewer's yeast].. PubMed. 99(7). 808–13.
15.
Kimura, Kenjiro, Sayaka Inokuchi, Isao Shirato, et al.. (1997). Location and action of angiotensin II type 1 receptor in the renal microcirculation.. PubMed. 63. S201–4. 11 indexed citations
16.
Ito, Toshio, et al.. (1991). Long-term intermittent administration of interferon-α in patients with chronic non-A, non-B hepatitis. Gastroenterologia Japonica. 26(2). 187–193. 2 indexed citations
18.
Hashimoto, Kozo, Shinya Makino, Ryuto Hirasawa, et al.. (1989). Abnormalities in the Hypothalamo-Pituitary-Adrenal Axis in Spontaneously Hypertensive Rats during Development of Hypertension. Endocrinology. 125(3). 1161–1167. 78 indexed citations
19.
Setsune, Jun‐ichiro, et al.. (1986). Facile Formation of Semi-Reduced Radicals of cis-N,N′-Diacylindigos by Visible-Light-Induced One-Electron Transfer from Tertiary Amines. Chemistry Letters. 15(8). 1393–1396. 3 indexed citations
20.
Maekawa, T, et al.. (1971). Arteriosclerosis, Coagulation and Fibrinolysis. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 8(3). 111–127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026